Selenium and Selenoproteins at the Intersection of Type 2 Diabetes and Thyroid Pathophysiology
Type 2 diabetes (T2D) is considered one of the largest global public-health concerns, affecting approximately more than 400 million individuals worldwide. The pathogenesis of T2D is very complex and, among the modifiable risk factors, selenium (Se) has recently emerged as a determinant of T2D pathog...
Saved in:
Main Authors: | Francesca Gorini (Author), Cristina Vassalle (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selenium and Selenoproteins in Gut Inflammation-A Review
by: Shaneice K. Nettleford, et al.
Published: (2018) -
Selenium and thyroid dysfunction: from pathophysiology to treatment options
by: Ekaterina N. Dudinskaya
Published: (2024) -
Type 2 Diabetes and Oxidative Stress and Inflammation: Pathophysiological Mechanisms and Possible Therapeutic Options
by: Cristina Vassalle, et al.
Published: (2022) -
Neonatal Selenium Deficiency Decreases Selenoproteins in the Lung and Impairs Pulmonary Alveolar Development
by: Laura G. Sherlock, et al.
Published: (2022) -
Oxidative Stress Biomarkers in the Relationship between Type 2 Diabetes and Air Pollution
by: Francesca Gorini, et al.
Published: (2021)